EXPANDING THE BOUNDARIES OF DRUG DISCOVERY
With a singular goal to improve patient lives, Hyku is pioneering precise covalent targeting of disease-causing proteins and transforming conventional treatment paradigms
Hyku Biosciences is developing small molecule therapeutics with novel mechanisms of action to potently inactivate proteins that drive disease progression.
To achieve this goal, we are pioneering our proprietary Hyku platform, which identifies compounds that covalently bind non-cysteine amino acids to facilitate development of novel therapies that can address current challenges associated with many disease targets, including selectivity, druggability, and resistance.
The people that make Hyku Biosciences
Our people are at the core of everything we will accomplish. We are united in our mission to improve patient lives by pushing the scientific boundaries of covalent medicines. Our Hyku community is composed of diverse individuals that hold respect, collaboration and innovation central to our efforts.
Join the team
We are always interested in talented individuals to join our team.
Contact Us
1050 Waltham Street, 3rd Floor
Lexington, MA, 02421